Global Antibody-drug Conjugate Market Insights and Forecast to 2026

Global Antibody-drug Conjugate Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Antibody-drug Conjugate Product Introduction
1.2 Market Segments
1.3 Key Antibody-drug Conjugate Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibody-drug Conjugate Market Size Growth Rate by Type
1.4.2 Adcetris
1.4.3 Kadcyla
1.5 Market by Application
1.5.1 Global Antibody-drug Conjugate Market Size Growth Rate by Application
1.5.2 Breast Cancer
1.5.3 Lymphoma
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibody-drug Conjugate Market Size, Estimates and Forecasts
2.1.1 Global Antibody-drug Conjugate Revenue 2015-2026
2.1.2 Global Antibody-drug Conjugate Sales 2015-2026
2.2 Global Antibody-drug Conjugate, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antibody-drug Conjugate Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antibody-drug Conjugate Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antibody-drug Conjugate Competitor Landscape by Players
3.1 Antibody-drug Conjugate Sales by Manufacturers
3.1.1 Antibody-drug Conjugate Sales by Manufacturers (2015-2020)
3.1.2 Antibody-drug Conjugate Sales Market Share by Manufacturers (2015-2020)
3.2 Antibody-drug Conjugate Revenue by Manufacturers
3.2.1 Antibody-drug Conjugate Revenue by Manufacturers (2015-2020)
3.2.2 Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibody-drug Conjugate Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibody-drug Conjugate Revenue in 2019
3.2.5 Global Antibody-drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antibody-drug Conjugate Price by Manufacturers
3.4 Antibody-drug Conjugate Manufacturing Base Distribution, Product Types
3.4.1 Antibody-drug Conjugate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody-drug Conjugate Product Type
3.4.3 Date of International Manufacturers Enter into Antibody-drug Conjugate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antibody-drug Conjugate Market Size by Type (2015-2020)
4.1.1 Global Antibody-drug Conjugate Sales by Type (2015-2020)
4.1.2 Global Antibody-drug Conjugate Revenue by Type (2015-2020)
4.1.3 Antibody-drug Conjugate Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibody-drug Conjugate Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibody-drug Conjugate Sales Forecast by Type (2021-2026)
4.2.2 Global Antibody-drug Conjugate Revenue Forecast by Type (2021-2026)
4.2.3 Antibody-drug Conjugate Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibody-drug Conjugate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antibody-drug Conjugate Market Size by Application (2015-2020)
5.1.1 Global Antibody-drug Conjugate Sales by Application (2015-2020)
5.1.2 Global Antibody-drug Conjugate Revenue by Application (2015-2020)
5.1.3 Antibody-drug Conjugate Price by Application (2015-2020)
5.2 Antibody-drug Conjugate Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibody-drug Conjugate Sales Forecast by Application (2021-2026)
5.2.2 Global Antibody-drug Conjugate Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibody-drug Conjugate Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antibody-drug Conjugate by Country
6.1.1 North America Antibody-drug Conjugate Sales by Country
6.1.2 North America Antibody-drug Conjugate Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antibody-drug Conjugate Market Facts & Figures by Type
6.3 North America Antibody-drug Conjugate Market Facts & Figures by Application
7 Europe
7.1 Europe Antibody-drug Conjugate by Country
7.1.1 Europe Antibody-drug Conjugate Sales by Country
7.1.2 Europe Antibody-drug Conjugate Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibody-drug Conjugate Market Facts & Figures by Type
7.3 Europe Antibody-drug Conjugate Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antibody-drug Conjugate by Region
8.1.1 Asia Pacific Antibody-drug Conjugate Sales by Region
8.1.2 Asia Pacific Antibody-drug Conjugate Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antibody-drug Conjugate Market Facts & Figures by Type
8.3 Asia Pacific Antibody-drug Conjugate Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antibody-drug Conjugate by Country
9.1.1 Latin America Antibody-drug Conjugate Sales by Country
9.1.2 Latin America Antibody-drug Conjugate Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antibody-drug Conjugate Market Facts & Figures by Type
9.3 Central & South America Antibody-drug Conjugate Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antibody-drug Conjugate by Country
10.1.1 Middle East and Africa Antibody-drug Conjugate Sales by Country
10.1.2 Middle East and Africa Antibody-drug Conjugate Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antibody-drug Conjugate Market Facts & Figures by Type
10.3 Middle East and Africa Antibody-drug Conjugate Market Facts & Figures by Application
11 Company Profiles
11.1 Agensys
11.1.1 Agensys Corporation Information
11.1.2 Agensys Description and Business Overview
11.1.3 Agensys Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Agensys Antibody-drug Conjugate Products Offered
11.1.5 Agensys Related Developments
11.2 Concortis Biotherapeutics
11.2.1 Concortis Biotherapeutics Corporation Information
11.2.2 Concortis Biotherapeutics Description and Business Overview
11.2.3 Concortis Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Concortis Biotherapeutics Antibody-drug Conjugate Products Offered
11.2.5 Concortis Biotherapeutics Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description and Business Overview
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Antibody-drug Conjugate Products Offered
11.3.5 Sanofi Related Developments
11.4 Celldex Therapeutics
11.4.1 Celldex Therapeutics Corporation Information
11.4.2 Celldex Therapeutics Description and Business Overview
11.4.3 Celldex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celldex Therapeutics Antibody-drug Conjugate Products Offered
11.4.5 Celldex Therapeutics Related Developments
11.5 Synthon Holding BV
11.5.1 Synthon Holding BV Corporation Information
11.5.2 Synthon Holding BV Description and Business Overview
11.5.3 Synthon Holding BV Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Synthon Holding BV Antibody-drug Conjugate Products Offered
11.5.5 Synthon Holding BV Related Developments
11.1 Agensys
11.1.1 Agensys Corporation Information
11.1.2 Agensys Description and Business Overview
11.1.3 Agensys Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Agensys Antibody-drug Conjugate Products Offered
11.1.5 Agensys Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antibody-drug Conjugate Market Estimates and Projections by Region
12.1.1 Global Antibody-drug Conjugate Sales Forecast by Regions 2021-2026
12.1.2 Global Antibody-drug Conjugate Revenue Forecast by Regions 2021-2026
12.2 North America Antibody-drug Conjugate Market Size Forecast (2021-2026)
12.2.1 North America: Antibody-drug Conjugate Sales Forecast (2021-2026)
12.2.2 North America: Antibody-drug Conjugate Revenue Forecast (2021-2026)
12.2.3 North America: Antibody-drug Conjugate Market Size Forecast by Country (2021-2026)
12.3 Europe Antibody-drug Conjugate Market Size Forecast (2021-2026)
12.3.1 Europe: Antibody-drug Conjugate Sales Forecast (2021-2026)
12.3.2 Europe: Antibody-drug Conjugate Revenue Forecast (2021-2026)
12.3.3 Europe: Antibody-drug Conjugate Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antibody-drug Conjugate Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antibody-drug Conjugate Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antibody-drug Conjugate Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antibody-drug Conjugate Market Size Forecast by Region (2021-2026)
12.5 Latin America Antibody-drug Conjugate Market Size Forecast (2021-2026)
12.5.1 Latin America: Antibody-drug Conjugate Sales Forecast (2021-2026)
12.5.2 Latin America: Antibody-drug Conjugate Revenue Forecast (2021-2026)
12.5.3 Latin America: Antibody-drug Conjugate Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antibody-drug Conjugate Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antibody-drug Conjugate Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antibody-drug Conjugate Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antibody-drug Conjugate Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Antibody-drug Conjugate Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody-drug Conjugate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Antibody-drug Conjugate Market Segments
Table 2. Ranking of Global Top Antibody-drug Conjugate Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibody-drug Conjugate Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Adcetris
Table 5. Major Manufacturers of Kadcyla
Table 6. Global Antibody-drug Conjugate Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Antibody-drug Conjugate Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Antibody-drug Conjugate Sales by Regions 2015-2020 (K Units)
Table 9. Global Antibody-drug Conjugate Sales Market Share by Regions (2015-2020)
Table 10. Global Antibody-drug Conjugate Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Antibody-drug Conjugate Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Antibody-drug Conjugate Sales Share by Manufacturers (2015-2020)
Table 13. Global Antibody-drug Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Antibody-drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugate as of 2019)
Table 15. Antibody-drug Conjugate Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Antibody-drug Conjugate Price (2015-2020) (USD/Unit)
Table 18. Antibody-drug Conjugate Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Antibody-drug Conjugate Product Type
Table 20. Date of International Manufacturers Enter into Antibody-drug Conjugate Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Antibody-drug Conjugate Sales by Type (2015-2020) (K Units)
Table 23. Global Antibody-drug Conjugate Sales Share by Type (2015-2020)
Table 24. Global Antibody-drug Conjugate Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Antibody-drug Conjugate Revenue Share by Type (2015-2020)
Table 26. Antibody-drug Conjugate Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Antibody-drug Conjugate Sales by Application (2015-2020) (K Units)
Table 28. Global Antibody-drug Conjugate Sales Share by Application (2015-2020)
Table 29. North America Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 30. North America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 31. North America Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 33. North America Antibody-drug Conjugate Sales by Type (2015-2020) (K Units)
Table 34. North America Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
Table 35. North America Antibody-drug Conjugate Sales by Application (2015-2020) (K Units)
Table 36. North America Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Table 37. Europe Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 38. Europe Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 39. Europe Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 41. Europe Antibody-drug Conjugate Sales by Type (2015-2020) (K Units)
Table 42. Europe Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
Table 43. Europe Antibody-drug Conjugate Sales by Application (2015-2020) (K Units)
Table 44. Europe Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Antibody-drug Conjugate Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Antibody-drug Conjugate Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Antibody-drug Conjugate Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Antibody-drug Conjugate Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Table 53. Latin America Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 54. Latin America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 57. Latin America Antibody-drug Conjugate Sales by Type (2015-2020) (K Units)
Table 58. Latin America Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
Table 59. Latin America Antibody-drug Conjugate Sales by Application (2015-2020) (K Units)
Table 60. Latin America Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Antibody-drug Conjugate Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Antibody-drug Conjugate Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Table 69. Agensys Corporation Information
Table 70. Agensys Description and Major Businesses
Table 71. Agensys Antibody-drug Conjugate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Agensys Product
Table 73. Agensys Recent Development
Table 74. Concortis Biotherapeutics Corporation Information
Table 75. Concortis Biotherapeutics Description and Major Businesses
Table 76. Concortis Biotherapeutics Antibody-drug Conjugate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Concortis Biotherapeutics Product
Table 78. Concortis Biotherapeutics Recent Development
Table 79. Sanofi Corporation Information
Table 80. Sanofi Description and Major Businesses
Table 81. Sanofi Antibody-drug Conjugate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Sanofi Product
Table 83. Sanofi Recent Development
Table 84. Celldex Therapeutics Corporation Information
Table 85. Celldex Therapeutics Description and Major Businesses
Table 86. Celldex Therapeutics Antibody-drug Conjugate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Celldex Therapeutics Product
Table 88. Celldex Therapeutics Recent Development
Table 89. Synthon Holding BV Corporation Information
Table 90. Synthon Holding BV Description and Major Businesses
Table 91. Synthon Holding BV Antibody-drug Conjugate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Synthon Holding BV Product
Table 93. Synthon Holding BV Recent Development
Table 94. Global Antibody-drug Conjugate Sales Forecast by Regions (2021-2026) (K Units)
Table 95. Global Antibody-drug Conjugate Sales Market Share Forecast by Regions (2021-2026)
Table 96. Global Antibody-drug Conjugate Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 97. Global Antibody-drug Conjugate Revenue Market Share Forecast by Regions (2021-2026)
Table 98. North America: Antibody-drug Conjugate Sales Forecast by Country (2021-2026) (K Units)
Table 99. North America: Antibody-drug Conjugate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Europe: Antibody-drug Conjugate Sales Forecast by Country (2021-2026) (K Units)
Table 101. Europe: Antibody-drug Conjugate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Asia Pacific: Antibody-drug Conjugate Sales Forecast by Region (2021-2026) (K Units)
Table 103. Asia Pacific: Antibody-drug Conjugate Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Latin America: Antibody-drug Conjugate Sales Forecast by Country (2021-2026) (K Units)
Table 105. Latin America: Antibody-drug Conjugate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Middle East and Africa: Antibody-drug Conjugate Sales Forecast by Country (2021-2026) (K Units)
Table 107. Middle East and Africa: Antibody-drug Conjugate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Market Risks
Table 111. Main Points Interviewed from Key Antibody-drug Conjugate Players
Table 112. Antibody-drug Conjugate Customers List
Table 113. Antibody-drug Conjugate Distributors List
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody-drug Conjugate Product Picture
Figure 2. Global Antibody-drug Conjugate Sales Market Share by Type in 2020 & 2026
Figure 3. Adcetris Product Picture
Figure 4. Kadcyla Product Picture
Figure 5. Global Antibody-drug Conjugate Sales Market Share by Application in 2020 & 2026
Figure 6. Breast Cancer
Figure 7. Lymphoma
Figure 8. Antibody-drug Conjugate Report Years Considered
Figure 9. Global Antibody-drug Conjugate Market Size 2015-2026 (US$ Million)
Figure 10. Global Antibody-drug Conjugate Sales 2015-2026 (K Units)
Figure 11. Global Antibody-drug Conjugate Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
Figure 13. Global Antibody-drug Conjugate Sales Market Share by Region in 2019
Figure 14. Global Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
Figure 15. Global Antibody-drug Conjugate Revenue Market Share by Region in 2019
Figure 16. Global Antibody-drug Conjugate Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Antibody-drug Conjugate Revenue in 2019
Figure 18. Antibody-drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
Figure 20. Global Antibody-drug Conjugate Sales Market Share by Type in 2019
Figure 21. Global Antibody-drug Conjugate Revenue Market Share by Type (2015-2020)
Figure 22. Global Antibody-drug Conjugate Revenue Market Share by Type in 2019
Figure 23. Global Antibody-drug Conjugate Market Share by Price Range (2015-2020)
Figure 24. Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Figure 25. Global Antibody-drug Conjugate Sales Market Share by Application in 2019
Figure 26. Global Antibody-drug Conjugate Revenue Market Share by Application (2015-2020)
Figure 27. Global Antibody-drug Conjugate Revenue Market Share by Application in 2019
Figure 28. North America Antibody-drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Antibody-drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 31. North America Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 32. U.S. Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Antibody-drug Conjugate Market Share by Type in 2019
Figure 37. North America Antibody-drug Conjugate Market Share by Application in 2019
Figure 38. Europe Antibody-drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Antibody-drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 41. Europe Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 42. Germany Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Antibody-drug Conjugate Market Share by Type in 2019
Figure 53. Europe Antibody-drug Conjugate Market Share by Application in 2019
Figure 54. Asia Pacific Antibody-drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Antibody-drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Antibody-drug Conjugate Sales Market Share by Region in 2019
Figure 57. Asia Pacific Antibody-drug Conjugate Revenue Market Share by Region in 2019
Figure 58. China Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Antibody-drug Conjugate Market Share by Type in 2019
Figure 81. Asia Pacific Antibody-drug Conjugate Market Share by Application in 2019
Figure 82. Latin America Antibody-drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Antibody-drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 85. Latin America Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 86. Mexico Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Antibody-drug Conjugate Market Share by Type in 2019
Figure 93. Latin America Antibody-drug Conjugate Market Share by Application in 2019
Figure 94. Middle East and Africa Antibody-drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Antibody-drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 98. Turkey Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Antibody-drug Conjugate Market Share by Type in 2019
Figure 105. Middle East and Africa Antibody-drug Conjugate Market Share by Application in 2019
Figure 106. North America Antibody-drug Conjugate Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Antibody-drug Conjugate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Antibody-drug Conjugate Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Antibody-drug Conjugate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Antibody-drug Conjugate Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Antibody-drug Conjugate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Antibody-drug Conjugate Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Antibody-drug Conjugate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Antibody-drug Conjugate Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Antibody-drug Conjugate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs